Trends in Guideline-Concordant Care for Inflammatory Breast Cancer
In this cohort study of women with nonmetastatic IBC, there were no disparities observed in GCC receipt, but only 25.1% of patients with IBC received all forms of GCC for which they were eligible. Among those who received GCC, there was no racial disparity in survival for triple-negative IBC, suggesting opportunities to improve equity through standardization of care.
Authors
- Brian Diskin (ORCID: https://orcid.org/0000-0001-5167-9824)
- Amy Xu (ORCID: https://orcid.org/0000-0001-9650-9458)
- Audree B. Tadros (ORCID: https://orcid.org/0000-0003-3588-251X)
- Varadan Sevilimedu (ORCID: https://orcid.org/0000-0002-0938-9396)
- Oluwadamilola M. Fayanju (ORCID: https://orcid.org/0000-0002-0876-975X)
- Yoshiko Iwai (ORCID: https://orcid.org/0000-0001-9759-384X)
- Perri Vingan
- Jonas A. Nelson (ORCID: https://orcid.org/0000-0003-0329-4422)
- Monica Morrow
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Harvard University (US)
- Massachusetts General Hospital (US)
- Saint John's Health Center (US)
- Penn Center for AIDS Research (US)
- Abramson Cancer Center (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.54506
- Citations
- 8
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 7.49